Advertisement
New Zealand markets close in 3 hours 51 minutes
  • NZX 50

    11,856.73
    -15.91 (-0.13%)
     
  • NZD/USD

    0.6150
    -0.0021 (-0.34%)
     
  • NZD/EUR

    0.5721
    -0.0020 (-0.35%)
     
  • ALL ORDS

    7,976.70
    -25.80 (-0.32%)
     
  • ASX 200

    7,725.60
    -24.10 (-0.31%)
     
  • OIL

    77.88
    -0.74 (-0.94%)
     
  • GOLD

    2,319.90
    +1.90 (+0.08%)
     
  • NASDAQ

    19,576.92
    +111.74 (+0.57%)
     
  • FTSE

    8,163.67
    -51.81 (-0.63%)
     
  • Dow Jones

    38,647.10
    -65.11 (-0.17%)
     
  • DAX

    18,265.68
    -365.18 (-1.96%)
     
  • Hang Seng

    18,112.63
    +174.79 (+0.97%)
     
  • NIKKEI 225

    38,569.46
    -151.01 (-0.39%)
     
  • NZD/JPY

    96.6670
    -0.1530 (-0.16%)
     

Exploring High Insider Ownership Growth Companies On Euronext Paris

Amidst a backdrop of cautious optimism in European markets, where France's CAC 40 Index saw a slight decline last week, investors continue to seek opportunities that align with both growth potential and stability. High insider ownership in growth companies on Euronext Paris can be an attractive feature for investors, signaling confidence from those who know the company best during uncertain times.

Top 10 Growth Companies With High Insider Ownership In France

Name

Insider Ownership

Earnings Growth

VusionGroup (ENXTPA:VU)

13.3%

24.4%

Groupe OKwind Société anonyme (ENXTPA:ALOKW)

24.8%

37.7%

WALLIX GROUP (ENXTPA:ALLIX)

19.9%

101.4%

La Française de l'Energie (ENXTPA:FDE)

20.1%

37.6%

Adocia (ENXTPA:ADOC)

12.8%

104.5%

OSE Immunotherapeutics (ENXTPA:OSE)

24.9%

92.9%

Icape Holding (ENXTPA:ALICA)

30.2%

26.1%

Arcure (ENXTPA:ALCUR)

21.4%

41.7%

Munic (ENXTPA:ALMUN)

29.2%

150%

MedinCell (ENXTPA:MEDCL)

16.4%

68.8%

Click here to see the full list of 21 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener.

ADVERTISEMENT

Below we spotlight a couple of our favorites from our exclusive screener.

Lectra

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Lectra SA offers industrial intelligence solutions tailored for the fashion, automotive, and furniture sectors, with a market capitalization of approximately €1.24 billion.

Operations: The company generates its revenue from the Americas and Asia-Pacific regions, totaling €170.33 million and €110.28 million respectively.

Insider Ownership: 19.6%

Revenue Growth Forecast: 11.3% p.a.

Lectra, a French company, reported a slight decline in net income and EPS in its latest quarter with sales rising to €129.56 million. Despite trading 20.4% below its estimated fair value, Lectra is poised for robust growth with earnings expected to increase by 28.6% annually, outpacing the French market's forecast of 10.9%. However, its projected return on equity of 13.3% could be considered modest. No significant insider transactions were reported recently, maintaining stable insider ownership levels.

ENXTPA:LSS Earnings and Revenue Growth as at May 2024
ENXTPA:LSS Earnings and Revenue Growth as at May 2024

MedinCell

Simply Wall St Growth Rating: ★★★★★☆

Overview: MedinCell S.A. is a French pharmaceutical company specializing in the development of long-acting injectable medications across multiple therapeutic areas, with a market capitalization of approximately €409.68 million.

Operations: The company generates its revenue primarily from the pharmaceuticals segment, totaling approximately €14.13 million.

Insider Ownership: 16.4%

Revenue Growth Forecast: 40.1% p.a.

MedinCell, a French biotech firm, has recently faced setbacks with its Phase 3 trial for F14 not meeting its primary endpoint in knee replacement recovery. However, the drug showed significant improvements in secondary measures such as knee range of motion and swelling reduction. MedinCell's collaboration with Teva on UZEDY™ for schizophrenia treatment has reached commercial stages, expecting substantial revenues. Despite recent share price volatility and shareholder dilution over the past year, MedinCell is forecasted to grow revenue by 40.1% annually and become profitable within three years.

ENXTPA:MEDCL Earnings and Revenue Growth as at May 2024
ENXTPA:MEDCL Earnings and Revenue Growth as at May 2024

OVH Groupe

Simply Wall St Growth Rating: ★★★★☆☆

Overview: OVH Groupe S.A. operates globally, offering public and private cloud services, shared hosting, and dedicated server solutions with a market capitalization of approximately €1.19 billion.

Operations: The company generates revenue primarily through three segments: Public Cloud (€140.71 million), Private Cloud (€514.59 million), and Web Cloud (€179.45 million).

Insider Ownership: 10.5%

Revenue Growth Forecast: 11.3% p.a.

OVH Groupe S.A., a French cloud services provider, is navigating through a transformative phase with significant leadership changes and strategic expansions. Recently, the company reported improved half-year sales of €486.09 million and reduced net losses. With high insider ownership, OVH is expected to become profitable in three years amidst a volatile share price environment. Revenue growth forecasts at 11.3% per year outpace the French market's average, despite a forecasted low return on equity of 3.8%.

ENXTPA:OVH Ownership Breakdown as at May 2024
ENXTPA:OVH Ownership Breakdown as at May 2024

Make It Happen

Ready For A Different Approach?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include ENXTPA:LSS ENXTPA:MEDCL and ENXTPA:OVH.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com